Zdrowie i gospodarka · 14/02/2022
FDA Classifies Adjunctive Predictive Cardiovascular Indicator as Class II Device with Special Controls
The FDA has classified the adjunctive predictive cardiovascular indicator as a Class II device with special controls, aiming to ensure its safety and effectiveness while enhancing patients' access to innovative devices.
Source: Federal Register — Food and Drug AdministrationOpen original release →